Ischemic heart disease
Conditions
Interventions
CIHD patient control group:Administer aspirin 100mg qd, atorvastatin calcium 20mg qd (patients with hypertension, diabetes, etc., continue corresponding medications for control), for 4 weeks.
CIHD patients Chinese herbal medicine group:On the basis of the control group, Compound Tianlong Decoction was administered daily (1 dose, by decoction) for 4 weeks.
CIHD patients in the acupuncture and Chinese herbal medicine combination group:On the basis of the herbal medicine group, acupuncture was administered at the Neiguan (PC6), Shenmen (HT7), and Zusanli
A Control Group of AIHD Patients:Standardized Western medical treatment, 4 weeks
AIHD Patients Chinese Herbal Medicine Group:On the basis of the control group, Compound Tianlong Decoction was administered daily (1 dose, by decoction) for 4 weeks.
AIHD patients combined acupuncture and herbal medicine group.:On the basis of the herbal medicine group, acupuncture was administered at the Neiguan (PC6), Shenmen (HT7), and Zusanli (ST36) acupoints,
Sponsors
Affiliated Hospital of Chinese Medicine of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria of Western medicine, i.e., carotid artery color Doppler ultrasound shows the formation of atherosclerotic plaques in the carotid artery, with a lumen stenosis rate of <70%, or meets the diagnostic criteria for acute coronary syndrome, and has undergone revascularization (including intravenous drug thrombolysis or percutaneous coronary intervention) for 1 week; (2) Confirmed as "qi deficiency with phlegm and blood stasis" according to traditional Chinese medicine differential diagnosis; (3) Participants aged between 18-75 years at the time of enrollment; (4) All participants agreed to and signed the informed consent for this study.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the diagnostic criteria of Western medicine or Traditional Chinese Medicine (TCM); (2) Individuals who have undergone surgery, severe trauma, shock, infectious diseases, or non-infectious inflammatory diseases within the past month; (3) Patients with severe primary diseases of the liver, kidneys, or hematopoietic system, or those with diabetic ketoacidosis; (4) Patients who are in the pregnancy or lactation period; (5) Patients with allergic constitutions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine (TCM) syndrome improvement status;Creatine kinase isoenzyme; | — |
Secondary
| Measure | Time frame |
|---|---|
| electrocardiogram;Carotid artery color Doppler ultrasound;soluble growth-stimulating expression gene 2 protein;Interleukin-33;Growth Differentiation Factor 15;Troponin;Myoglobin; | — |
Countries
China
Contacts
Public ContactYe Xi
The Affiliated TCM Hospital of Guangzhou Medical University
Outcome results
None listed